Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. Its Immune-stimulating Antibody Conjugates (ISAC) eliminate tumors following systemic administration in preclinical studies and results in the development of immunological memory. The company also develops Myeloid Modulator Platform that reawakens myeloid cells to attack tumor cells.